Biodefense Market: Industry Analysis, Trend, Growth, Opportunity, Forecast 2028 The study on the global market for Biodefense evaluated the historical and current performance of this market, especially highlighting the key trends and growth opportunities. According to the study, the rising demand for this product is driving the global market for Global Biodefense significantly. The expansion in the various related industry is also expected to reflect positively on the sales of Global Biodefense product over the next few years. Browse key industry insights spread across 110 pages with 164 market data tables & 8 figures & charts from the report, “Biodefense Market Analysis By Product (Vaccines {Anthrax, Smallpox, Botulism}, Biothreat Detection Devices {Samplers, Detectors/Triggering Devices, Identifiers, Assays and Reagents}, Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2022– 2028” in detail along with the table of contents: https://www.gminsights.com/industryanalysis/biodefense-market In recent years, governments across the globe have taken various initiatives to instill biodefense mechanisms against bioterrorism. Biothreats not only harm human health but also human resources, which impacts the economic growth of a country. Notably, the COVID19 pandemic has prompted innovations in the development of vaccinations and biothreat detection devices. To that effect, in October 2021, the World Health Organization (WHO) called for a change in diagnostics globally to fill the biodefense gap created between LICs (low-income countries) and developed nations, following the launch of the Test-to-Treat initiative by U.S. President Biden, which offers free treatment and testing kits to all American citizens who test positive. As a result, supportive government initiatives for formulating innovative biodefense solutions have been beneficial for biodefense industry growth. Furthermore, key players in the sector have been investing in consistent improvement and technological advancements in biodefense mechanisms, thereby fostering biodefense market outlook. To cite an instance, in March 2022, Bavarian Nordic, a major biotechnology firm, inked a license & supply deal with Nuance Pharma, a China-based pharmaceutical company. The agreement was undertaken to facilitate the development as well as commercialization of MVA-BN RSV, Bavarian Nordic's vaccine candidate that targets respiratory syncytial virus (RSV) in older adults. In another instance, in October 2021, Smiths Detection Group Ltd., a leading enterprise in threat detection and security screening tech, announced that its air sampler BioFlash Biological Identifier device is capable of detecting SARS-CoV-2 variants. The air sampler was
© 2022 Global Market Insights Inc. All Rights Reserved
www.gminsights.com